Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine ER vs placebo in Japanese outpatients with generalized anxiety disorder
jRCT2031220156Completed
- Sponsor
- Mylan
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in generalized anxiety disorder (GAD) comparing Venlafaxine ER with Placebo (2 arms). Primary endpoint: Change in HAM-A total score from baseline to end of treatment. Started Aug 2022; status: completed.
02
Drugs
venlafaxine
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on jRCT2031220156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220156.